State Street’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.7K | Hold |
121,850
| – | – | ﹤0.01% | 4132 |
|
|
2025
Q1 | $51.3K | Hold |
121,850
| – | – | ﹤0.01% | 4092 |
|
|
2024
Q4 | $85.5K | Buy |
121,850
+59,100
| +94% | +$41.4K | ﹤0.01% | 4021 |
|
|
2024
Q3 | $29.4K | Hold |
62,750
| – | – | ﹤0.01% | 4179 |
|
|
2024
Q2 | $104K | Buy |
62,750
+12,000
| +24% | +$19.9K | ﹤0.01% | 4003 |
|
|
2024
Q1 | $92.4K | Hold |
50,750
| – | – | ﹤0.01% | 4043 |
|
|
2023
Q4 | $93.9K | Hold |
50,750
| – | – | ﹤0.01% | 4067 |
|
|
2023
Q3 | $73.1K | Buy |
50,750
+20,500
| +68% | +$29.5K | ﹤0.01% | 4190 |
|
|
2023
Q2 | $55.4K | Hold |
30,250
| – | – | ﹤0.01% | 4394 |
|
|
2023
Q1 | $59.9K | Hold |
30,250
| – | – | ﹤0.01% | 4462 |
|
|
2022
Q4 | $63.5K | Buy |
30,250
+15,600
| +106% | +$32.8K | ﹤0.01% | 4497 |
|
|
2022
Q3 | $28K | Buy |
+14,650
| New | +$28K | ﹤0.01% | 4777 |
|